Last reviewed · How we verify

NCT07148700

Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment

Recruiting now Last updated 29 August 2025
What this trial tests

trial in PARKINSON DISEASE (Disorder) in 40 participants. Currently enrolling.

Timeline
1 May 2025
Primary endpoint
25 August 2025
30 August 2025

Quick facts

Lead sponsorBezmialem Vakif University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment40
Start date1 May 2025
Primary completion25 August 2025
Estimated completion30 August 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Bezmialem Vakif University

Who can join

Adults 40 to 80, any sex, with PARKINSON DISEASE (Disorder) or Parkinson. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduction: Falls are common in Parkinson's disease (PD), affecting 30-90% of patients annually, with more than half experiencing recurrent falls. Identifying balance assessment tools that are both practical and predictive of fall risk is therefore essential. This study aimed to investigate the relationship between fall frequency and three balance assessment tools: the Biodex Balance System (objective), the Falls Efficacy Scale-International (FES-I) (self-reported), and the Mini-Balance Evaluation Systems Test (Mini-BESTest) (functional). Methods: Patients with PD at Hoehn and Yahr stages 1-3 will be included in the study. Fall data will be collected using a fall diary, while objective balance will be assessed with the Biodex Balance System, functional performance will be evaluated with the Mini-BESTest, and self-reported balance confidence will be measured with the FES-I.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for PARKINSON DISEASE (Disorder)

Currently open trials in the same condition.

Other Bezmialem Vakif University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07148700.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing